CASTRATION-RESISTANT PROSTATIC CANCER
Clinical trials for CASTRATION-RESISTANT PROSTATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-RESISTANT PROSTATIC CANCER trials appear
Sign up with your email to follow new studies for CASTRATION-RESISTANT PROSTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise in slowing advanced prostate cancer
Disease control OngoingThis study tests whether adding the drug niraparib to standard treatment (abiraterone and prednisone) can slow the growth of metastatic prostate cancer that no longer responds to hormone therapy. About 765 men with specific genetic changes are participating. The main goal is to s…
Matched conditions: CASTRATION-RESISTANT PROSTATIC CANCER
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Prostate cancer drugs may cloud your mind: new study investigates
Knowledge-focused OngoingThis study looks at how certain hormone therapies for advanced prostate cancer might affect thinking skills like memory and attention. About 100 men who are already on these treatments will take thinking tests and have brain scans to see if there are changes. The goal is to under…
Matched conditions: CASTRATION-RESISTANT PROSTATIC CANCER
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated May 16, 2026 23:36 UTC